Firms
BNP Paribas Fortis Private Equity
Brussels, Belgium
BNP Paribas Fortis Private Equity is the Belgian bank group’s long-term institutional private-equity investing platform. It invests directly through minority equity and mezzanine financing and indirectly through private-equity funds, focusing on Belgian companies across sectors apart from real estate. Its own current policy describes indicativeEUR1M–50M tickets, typicallyEUR3M–15M; these are policy ranges rather than actual company checks. It explicitly operates without a closed-end fund timetable, supporting patient investment horizons rather than a newly raised limited-life LP fund. The principal Belgian investment holding, BNP Paribas Fortis Private Equity Belgium NV, is an active separate legal subsidiary BE0421.883.286, incorporated September16,1981; the bank’s historical brochure dates private-equity operations from1982. Current official KBO and GLEIF records verify that legal identity and registered Warandeberg3 Brussels address. The holding’s six statutory directors are Raf Moons, Renaat Denolf, Frank Claeys, Annegreet De Smedt, Stéphane Vermeire and Sandra Wilikens. Related BNP Paribas Fortis Private Equity Management NV BE0438.091.788 was incorporated July25,1989 and absorbed Fortis Private Equity Venture Belgium BE0431.044.244 inSeptember2014; it remains a distinct governance/service entity. The platform description qualifies both legal units rather than claiming that every broadly named historical company check belongs to one particular subscribing subsidiary. BNP Paribas parentInvestor and other Fortis entities remain separate; no parentbank cash check is duplicated. The current operating directory publishes16 named investment and support people headed by Raf Moons, with Renaat Denolf as COO. Four further source-confirmed holding directors bring the combined scoped public roster to20 unique people. Public titles and subsidiary-specific board positions are retained;20 is not a legal-entity employee headcount. Raf’s existing authentic portrait, biography and GFF permanent-representative roles are preserved. Three further genuine portraits are recovered: Renaat and Mark from the bank’s original historical team PDF, with current titles independently verified, and Sandra from the group’s own current named leadership page. Sixteen people lack a recoverable original portrait: the current bank directory’s16 direct asset paths return denied or unavailable content, so no artificial images or anonymous silhouettes are used. The bank’s own current portfolio and historical original credentials document reMYND equity investments inSeptember2009 andMay2016. Issuer sources separately name this private-equity platform in the actualDecember2018 SeriesB andJanuary2021 second close; individual check amounts and exact2016/2018/2021 subscribing subsidiaries are unpublished. The official2009 ARKimedes-Fonds report identifies Fortis Private Equity Arkimedes as the older vehicle and reports EUR750,000 cumulative investments through December31,2009; this is not assigned as a September2009 event ticket. These direct company equity events differ from licensing or clinical partnerships. The platform and PMV also act as advisory/service providers for Belgian Growth Fund structures; BGF I’s actual312M final commitment corpus and BGF II’s EUR247.5M committed corpus at its second close at the end ofDecember2025, reportedJanuary14,2026 with fundraising still open belong to those separately constituted funds, not to new capital raised by this own-capital platform. BGF II is a distinct registered self-managed AICB with separate management/service arrangements. Bank AUM, institutional portfolio valuations,103M holding subscribedcapital and400K Management subscribedcapital are not LP closes or paid reMYND checks. No unsupported stand-alone fund close is created. The authentic BNP Paribas Fortis group logo is the published brand used by its private-equity pages and own primary investment release; no independent PE-specific mark is implied.
- Founded
- 1981
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Anne WautierInvestment Manager |
Annegreet De SmedtBoard Director — Belgium NV (qualified legal subsidiary) |
Eline BylLife Sciences Investment Associate |
Emiel De SaeytydInvestment Associate |
Frank ClaeysBoard Director — Belgium NV (qualified legal subsidiary) |
Julie De SchrijverInvestment Analyst |
Koen BroothaertsInvestment Director |
Laurence GrimardPerformance Analyst |
 Mark GevensBoard Director — Private Equity Management NV (qualified related entity) · Investment Director |
Patty TerrynCommercial Director |
 Raf MoonsBoard Director — Belgium NV (qualified legal subsidiary) · Board Director — Private Equity Management NV (qualified related entity) · Head of Private Equity |
 Renaat DenolfBoard Director — Belgium NV (qualified legal subsidiary) · Board Director — Private Equity Management NV (qualified related entity) · COO Private Equity |
 Sandra WilikensBoard Director — Belgium NV (qualified legal subsidiary) |
Sofie VermeulenInvestment Manager |
Sophie GoffartPersonal Assistant |
Steven Van DroogenbroeckInvestment Manager |
Stéphane VermeireBoard Director — Belgium NV (qualified legal subsidiary) |
Sven VermeulenInvestment Manager |
Sylvana LocurtoAdministrative Officer |
Toon FransInvestment Associate |
Co-investing
Bernard Majoie
reMYND€12M · 2018-12-18
Gemma Frisius Fund- reMYND€12M · 2018-12-18
